Evidence map›Paper›PMID 36456828›Full record

ArticleNature cell biology2022

Adherens junctions organize size-selective proteolytic hotspots critical for Notch signalling.

Minsuk Kwak, Kaden M Southard, Woon Ryoung Kim, Annie Lin, Nam Hyeong Kim, Ramu Gopalappa, Hyun Jung Lee, Minji An, Seo Hyun Choi, Yunmin Jung and 12 more

Open access · greenAbstract read
In one paragraph

Article in Nature cell biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. The blood-brain barrier: structure, regulation, and drug delivery.Signal transduction and targeted therapy · 2023
    Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 8 institutions in 2 countries.

Minsuk Kwak *Department of Otolaryngology, University of California, San Francisco, CA, USA.
Kaden M Southard *Department of Otolaryngology, University of California, San Francisco, CA, USA.
Woon Ryoung Kim *Department of Otolaryngology, University of California, San Francisco, CA, USA.
Annie LinDepartment of Otolaryngology, University of California, San Francisco, CA, USA.
Nam Hyeong KimDepartment of Otolaryngology, University of California, San Francisco, CA, USA.
Ramu GopalappaCenter for Nanomedicine, Institute for Basic Science (IBS), Seoul, Republic of Korea.
Hyun Jung LeeDepartment of Otolaryngology, University of California, San Francisco, CA, USA.
Minji AnCenter for Nanomedicine, Institute for Basic Science (IBS), Seoul, Republic of Korea.
Seo Hyun ChoiCenter for Nanomedicine, Institute for Basic Science (IBS), Seoul, Republic of Korea.
Yunmin JungCenter for Nanomedicine, Institute for Basic Science (IBS), Seoul, Republic of Korea.
Kunwoo NohCenter for Nanomedicine, Institute for Basic Science (IBS), Seoul, Republic of Korea.
Justin FarlowDepartment of Pharmaceutical Chemistry, University of California, San Francisco, CA, USA.
Anastasios GeorgakopoulosDepartment of Psychiatry and Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Nikolaos K RobakisDepartment of Psychiatry and Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Min K KangDepartment of Neurology, University of California, San Francisco, CA, USA.
Matthew L KutysDepartment of Cell and Tissue Biology, University of California, San Francisco, CA, USA.
Daeha SeoDepartment of Physics and Chemistry, DGIST, Daegu, Republic of Korea.
Hyongbum Henry KimCenter for Nanomedicine, Institute for Basic Science (IBS), Seoul, Republic of Korea.
Yong Ho KimSKKU Advanced Institute of Nanotechnology (SAINT), Sungkyunkwan University, Suwon, Republic of Korea.
Jinwoo CheonCenter for Nanomedicine, Institute for Basic Science (IBS), Seoul, Republic of Korea.
Zev J GartnerDepartment of Pharmaceutical Chemistry, University of California, San Francisco, CA, USA. zev.gartner@ucsf.edu.
Young-Wook JunDepartment of Otolaryngology, University of California, San Francisco, CA, USA. young-wook.jun@ucsf.edu.
University of California, San Francisco · USInstitute for Basic Science · KRUCSF Helen Diller Family Comprehensive Cancer Center · USIcahn School of Medicine at Mount Sinai · USSungkyunkwan University · KRYonsei University · KRDaegu Gyeongbuk Institute of Science and Technology · KRSeverance Hospital · KR

Funding

Regulation of ephrinB2-dependent angiogenesis by PS1 in normal and ADR01NS047229 · NINDS · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI GEORGAKOPOULOS, ANASTASIOS, ROBAKIS, NIKOLAOS K · 2004 to 2025
$8.3M
STRUCTURE &EXPRESSION OF THE B-PROTEIN-PRECURSOR GENER01AG008200 · NIA · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI ROBAKIS, NIKOLAOS K · 1988 to 2017
$5.6M
Spatiotemporal interrogation of molecular mechanobiololgy at the cell-cell interface with nanotechnology toolsR35GM134948 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Young-wook Jun · 2020 to 2026
$3.6M
Understanding breast cancer progression as a defect in the mechanics of tissue self-organizationU01CA244109 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GARTNER, ZEV JORDAN, GOGA, ANDREI · 2020 to 2024
$3.0M
Spatiotemporal Control of Dynamic Notch Signaling with Subcellular ResolutionR01GM112081 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JUN, YOUNG-WOOK · 2014 to 2018
$1.5M
Nanomodules for interrogating chemical, spatial, and mechanical dynamics of cell surface receptorsR01GM126542 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JUN, YOUNG-WOOK · 2017 to 2019
$951k
Non-canonical Notch1 regulation of proliferation and adherens junctions in breast cancerR00CA226366 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KUTYS, MATTHEW L · 2020 to 2022
$667k
Notch1 and APP signaling in cerebral microvascular dysfunctionR21AG072232 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JUN, YOUNG-WOOK, KUTYS, MATTHEW L · 2021 to 2021
$439k
NCI NIH HHS R00 CA226366NCI NIH HHS U01 CA244109NIA NIH HHS R01 AG008200NIA NIH HHS R21 AG072232NIGMS NIH HHS R01 GM112081NIGMS NIH HHS R01 GM126542NIGMS NIH HHS R35 GM134948NINDS NIH HHS R01 NS047229
6 · The paper itself

Abstract

Adherens junctions (AJs) create spatially, chemically and mechanically discrete microdomains at cellular interfaces. Here, using a mechanogenetic platform that generates artificial AJs with controlled protein localization, clustering and mechanical loading, we find that AJs also organize proteolytic hotspots for γ-secretase with a spatially regulated substrate selectivity that is critical in the processing of Notch and other transmembrane proteins. Membrane microdomains outside of AJs exclusively organize Notch ligand-receptor engagement (LRE microdomains) to initiate receptor activation. Conversely, membrane microdomains within AJs exclusively serve to coordinate regulated intramembrane proteolysis (RIP microdomains). They do so by concentrating γ-secretase and primed receptors while excluding full-length Notch. AJs induce these functionally distinct microdomains by means of lipid-dependent γ-secretase recruitment and size-dependent protein segregation. By excluding full-length Notch from RIP microdomains, AJs prevent inappropriate enzyme-substrate interactions and suppress spurious Notch activation. Ligand-induced ectodomain shedding eliminates size-dependent segregation, releasing Notch to translocate into AJs for processing by γ-secretase. This mechanism directs radial differentiation of ventricular zone-neural progenitor cells in vivo and more broadly regulates the proteolysis of other large cell-surface receptors such as amyloid precursor protein. These findings suggest an unprecedented role of AJs in creating size-selective spatial switches that choreograph γ-secretase processing of multiple transmembrane proteins regulating development, homeostasis and disease.

Indexed as

Amyloid Precursor Protein SecretasesLigandsAmyloid Precursor Protein SecretasesLigands

Identifiers

PMID36456828
PMCPMC10665132
OpenAlexW4311168415

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.